Pharma Research & Clinical Trial Monitor

Pull PubMed papers and ClinicalTrials.gov studies at scale. PMIDs, DOIs, abstracts, MeSH terms, NCT IDs, phases, sponsors, enrollment, primary outcomes, results. One row per record. Pay per row.

Publisher description, verbatim
Last 7 dayson this actor
Each one reaches followers by email the morning after.Follow this actor
Key figures30 readings
Price / 1k$15.00per 1,000 trial_row
Users / 30d0→ 0 over 30 readings
Users, all time2→ 0 over 30 readings
Runs / 30d113↓ 3 over 30 readings
Runs / user / mo—runs per monthly user
Standing
#67of 70

on PubMed, by users in the last 30 days among actors classified to this platform.

Recorded changes
  • 2026-09-05reviewsNew reviews+2 (2 total)+22 total
  • 2026-09-02schemaInput schema changed—on record
  • 2026-09-02contentREADME updated+31 characters+31characters
showing 3 of 3 in the last 30 days · followers get the next one by email

History

30 readings since 2026-08-27
Users / 30d30 readings
08-27→ 009-25
Users, all time30 readings
08-27→ 009-25
Runs / 30d30 readings
08-27↓ 309-25
Standing30 readings
08-27↑ 1309-25

Alternatives on PubMed

The actors either side of #67 of 70, ranked by users in the last 30 days. Same platform, adjacent adoption — the comparable set.

all 70 on PubMed →
Sort
#ActorGradePrice / 1kUsers /30dSuccessRatingAgeFresh
62—RES$0.71 /1k06 total——5maging
63—RES$0.80 /1k011 total——7mfresh
64—RES$50.00 /1k07 total——6maging
65—EVT$2.25 /1k record-returned01 total——53dfresh
66—EVT$20.00 /1k search_papers03 total——5maging
67CEVT$15.00 /1k trial_row02 total100.0%5.0 (2)5magingThis
68—EVT$0.05 /1k apify-actor-start047 total——12mfresh
69—RENT$18.99 /mo033 total—5.0 (1)18maging
70—RES$4.00 /1k04 total——5mfresh

Follow this actor, compare it against its rivals, and get every overnight change in one morning report.

Publish it yourself? Claim your publisher page and its full history is yours free, forever.

Open in the app Claim this page

Numbers on this page are measured only by an independent census of the Apify Store — not self-reported.